Trial Profile
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on long-term use in patients with type 2 diabetes mellitus"
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda Pharma
- 01 Nov 2021 Status changed from active, no longer recruiting to completed.
- 23 Jul 2018 Planned End Date changed from 30 Apr 2021 to 31 Oct 2021.
- 23 Jul 2018 Planned primary completion date changed from 30 Apr 2021 to 31 Oct 2021.